ARCHIVES

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Litton’s New Fredrick Award Could Total Around $30 Million

July 30, 1976

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

February 22, 2013

NCAB Meeting Moved To October

July 20, 1979

In Brief: Indiana U. Planning “World Class” Cancer Center; UCLA Names Two New Cancer Control Directors

June 6, 1986

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005